| Noga, S J (1999) Engineering hematopoietic grafts using elutriation and positive cell selection to reduce GVHD. Cancer Treat Res 101:311-30 |
| Noga, S J; Seber, A; Davis, J M et al. (1998) CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment. J Hematother 7:151-7 |
| O'Donnell, P V; Jones, R J; Vogelsang, G B et al. (1998) CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies. Bone Marrow Transplant 22:947-55 |
| Noga, S J; Vogelsang, G B; Seber, A et al. (1997) CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity. Transplant Proc 29:728-32 |
